Anapharma
0419.195.297 · rovalta.com · 25/09/2026
Anapharma
Company — Normal situation.
Financial year 2023 · Closed on 31/12/2023
Overview
Identity
Source · BCE/KBOAnapharma is a company registered in Belgium. It employs on average 3,3 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0419.195.297
- Legal form
- Public limited company
- Contributed capital
- 123 940,00 €
- Latest accounts
- 31/12/2023
- Average workforce
- 3,3 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 45 filingsTrend over 18 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 235,1 k € | -28.3% | 327,8 k € | +17.3% | 279,5 k € | +9.4% | 255,6 k € | +0.7% | 253,8 k € |
| EBITDA | 55,9 k € | -60.8% | 142,5 k € | +26.3% | 112,8 k € | +12.2% | 100,6 k € | +7.0% | 94 k € |
| Operating result | 38,3 k € | -69.4% | 125,3 k € | +31.0% | 95,6 k € | +13.3% | 84,4 k € | +6.1% | 79,6 k € |
| Net result | 26,4 k € | -71.4% | 92,1 k € | +30.7% | 70,5 k € | +5.0% | 67,1 k € | -10.8% | 75,2 k € |
| Balance sheet | |||||||||
| Equity | 365,4 k € | +7.8% | 339 k € | -7.6% | 366,9 k € | -17.8% | 446,5 k € | +1.6% | 439,4 k € |
| Total assets | 680,9 k € | -16.7% | 817,5 k € | -2.1% | 835,3 k € | -4.5% | 874,5 k € | +15.4% | 757,7 k € |
| Cash | 63,8 k € | -75.2% | 256,9 k € | -17.5% | 311,4 k € | +52.8% | 203,7 k € | +9.5% | 186,1 k € |
| Debts | 315,5 k € | -34.1% | 478,5 k € | +2.1% | 468,4 k € | +10.9% | 422,4 k € | +32.9% | 317,9 k € |
| Other | |||||||||
| Workforce | 3,3 ETP | -10.8% | 3,7 ETP | -11.9% | 4,2 ETP | 0.0% | 4,2 ETP | 0.0% | 4,2 ETP |
Board of directors
Source · NBB, accounts to 31/12/20231 active · 20 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 25/07/2024 | 12/07/2023 | 14/07/2022 | 28/06/2021 | 20/08/2020 | 23/08/2019 |
| General meeting | 28/06/2024 | 30/06/2023 | 24/06/2022 | 25/06/2021 | 26/06/2020 | 28/06/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 45 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2023 | 28/06/2024 | 25/07/2024 | French | |
| Abridged model | 31/12/2022 | 30/06/2023 | 12/07/2023 | French | |
| Abridged model | 31/12/2021 | 24/06/2022 | 14/07/2022 | French | |
| Abridged model | 31/12/2020 | 25/06/2021 | 28/06/2021 | French | |
| Abridged model | 31/12/2019 | 26/06/2020 | 20/08/2020 | French | |
| Abridged model | 31/12/2018 | 28/06/2019 | 23/08/2019 | French | |
| Abridged model | 31/12/2017 | 29/06/2018 | 31/07/2018 | French | |
| Abridged model | 31/12/2016 | 30/06/2017 | 16/07/2017 | French | |
| Abridged model | 31/12/2015 | 22/07/2016 | 21/08/2016 | French | |
| Abridged model | 31/12/2014 | 26/06/2015 | 10/07/2015 | French | |
| Abridged model | 31/12/2013 | 04/07/2014 | 30/07/2014 | French | |
| Abridged model | 31/12/2012 | 12/07/2013 | 11/08/2013 | French | |
| Abridged model | 31/12/2011 | 03/08/2012 | 30/08/2012 | French | |
| Abridged model | 31/12/2010 | 02/09/2011 | 30/09/2011 | French | |
| Abridged model | 31/12/2009 | 25/06/2010 | 25/07/2010 | French | |
| Abridged model | 31/12/2008 | 26/06/2009 | 26/07/2009 | French | |
| Abridged model | 31/12/2007 | 27/06/2008 | 25/07/2008 | French | |
| Abridged model | 31/12/2006 | 29/06/2007 | 30/07/2007 | French | |
| Abridged model | 31/12/2005 | 30/06/2006 | 31/07/2006 | French | |
| Abridged model | 31/12/2004 | 24/06/2005 | 25/07/2005 | French | |
| Abridged model | 31/12/2003 | 25/06/2004 | 26/07/2004 | French | |
| Abridged model | 31/12/2002 | 27/06/2003 | 25/07/2003 | French | |
| Abridged model | 31/12/2001 | 28/06/2002 | 25/07/2002 | French | |
| Abridged model | 31/12/2000 | 29/06/2001 | 31/07/2001 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active · 20 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution23/07/2024RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
- Restructuring27/05/2024RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates31/01/2024SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Mandates17/01/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DEMISSIONS, NOMINATIONS
- Mandates07/02/2019DEMISSIONS, NOMINATIONS
- Mandates24/10/2017DEMISSIONS, NOMINATIONS
- Mandates12/01/2016DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 202326,4 k €↓
- 2023Name changePHARMACIE SANTIS ANS
- 2022Annual accounts 202292,1 k €↑
- 2021Annual accounts 202170,5 k €↑
- 2021Name changeAnapharma
- 2020Annual accounts 202067,1 k €↓
- 2019Annual accounts 201975,2 k €↑
- 2018Annual accounts 2018-25,4 k €↓
- 2017Annual accounts 20179,2 k €↓
- 2016Annual accounts 201613,5 k €↓
- 2015Annual accounts 201593,1 k €↑
- 2014Annual accounts 201459,4 k €↑
- 2013Annual accounts 201349,4 k €↑
- 2012Annual accounts 201221,4 k €↑
- 2011Annual accounts 201113,6 k €↓
- 2010Annual accounts 201030,7 k €↓
- 2009Annual accounts 200932,2 k €↓
- 2008Annual accounts 200834,3 k €↓
- 2007Annual accounts 2007134,7 k €↑
- 2006Annual accounts 200610 k €